<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120729</article-id><article-id pub-id-type="doi">10.23868/201808019</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Molecular mechanisms of neuroinflammation initiation and development in a model of post-traumatic stress disorder</article-title><trans-title-group xml:lang="ru"><trans-title>Молекулярные механизмы инициации и развития нейровоспаления в модели посттравматического стрессового расстройства</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tuchina</surname><given-names>O. P</given-names></name><name xml:lang="ru"><surname>Тучина</surname><given-names>О. П</given-names></name></name-alternatives><email>otuchina@kantiana.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sidorova</surname><given-names>M. V</given-names></name><name xml:lang="ru"><surname>Сидорова</surname><given-names>М. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Turkin</surname><given-names>A. V</given-names></name><name xml:lang="ru"><surname>Туркин</surname><given-names>А. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shvaiko</surname><given-names>D. A</given-names></name><name xml:lang="ru"><surname>Швайко</surname><given-names>Д. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shalaginova</surname><given-names>I. G</given-names></name><name xml:lang="ru"><surname>Шалагинова</surname><given-names>И. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vakolyuk</surname><given-names>I. A</given-names></name><name xml:lang="ru"><surname>Ваколюк</surname><given-names>И. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">School of Life Sciences, Immanuel Kant Baltic Federal University</institution></aff><aff><institution xml:lang="ru">Институт Живых Систем Балтийского Федерального Университета им. И. Канта</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-06-15" publication-format="electronic"><day>15</day><month>06</month><year>2018</year></pub-date><volume>13</volume><issue>2</issue><issue-title xml:lang="en">VOL 13, NO2 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 13, №2 (2018)</issue-title><fpage>47</fpage><lpage>55</lpage><history><date date-type="received" iso-8601-date="2023-01-05"><day>05</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Эко-Вектор</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/120729">https://genescells.ru/2313-1829/article/view/120729</self-uri><abstract xml:lang="en"><p>Neuroinflammation causes morphological and functional changes in the nervous tissue and it can be triggered by different kind of stressors. Progress of neuroinflammation as a result of post-traumatic stress disorder (PTSD) is associated with morphological changes in neurons and glial cells, as well as activation of microglia, however the exact molecular mechanisms of these changes are still unknown. In this review we discuss the connections between endocrine, immune and limbic systems during stress, the contributions of each system, the role of blood-brain barrier, as well as current methods and approaches in studying neuroinflammation.</p></abstract><trans-abstract xml:lang="ru"><p>Нейровоспаление как морфофункциональное изменение нервной ткани может возникать под воздействием различного рода стрессовых факторов. Развитие нейровоспаления на фоне посттравматического стрессового расстройства (ПТСР) связано с изменением морфологии нейронов и клеток глии, а также активацией микроглиальных клеток, однако конкретные молекулярные механизмы этих изменений до сих пор неизвестны. В данном обзоре рассматриваются связи между эндокринной, иммунной и лимбической системами при стрессе, их вклад в формирование ПТСР, роль гематоэнцефалического барьера, а также современные методические подходы к исследованию нейровоспаления.</p></trans-abstract><kwd-group xml:lang="en"><kwd>stress</kwd><kwd>cytokines</kwd><kwd>astrocytes</kwd><kwd>microglia</kwd><kwd>neuroimmune interactions</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>стресс</kwd><kwd>цитокины</kwd><kwd>астроциты</kwd><kwd>микроглия</kwd><kwd>нейро-иммунные взаимодействия</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>The National Center for Health Statistics [US] International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10), 2010, http://apps.who.int/classifications/icd10/ browse/2010/en.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Tovote P., Fadok J.P., Lüthi A. Neuronal circuits for fear and anxiety. Nat. Rev. Neurosci. 2015; 16: 317-31.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Domingos da Silveira da Luz A.C., Dias G.P., Nascimento Bevilaqua M.C. et al. Translational findings on brain-derived neurotrophic factor and anxiety: contributions from basic research to clinical practice. Neuropsychobiology 2013; 68: 129-38.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Matar M.A., Zohar J., Cohen H. Translationally relevant modeling of PTSD in rodents. Cell Tissue Res. 2013; 354: 127-39.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Wohleb E.S., McKim D.B., Shea D.T. et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol. Psychiatry 2014; 75: 970-81.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Deslauriers J., Powell S., Risbrough V.B. Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models. Curr. Opin. Behav. Sci. 2017; 14: 123-32.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Eraly S.A., Nievergelt C.M., Maihofer A.X. et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014; 71: 423.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>van Zuiden M., Heijnen C.J., Maas M. et al. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study. Psychoneuroendocrinology 2012; 37: 1822-36.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Jin J., Maren S. Fear renewal preferentially activates ventral hippocampal neurons projecting to both amygdala and prefrontal cortex in rats. Sci. Rep. 2015; 5: 8388.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Godsil B.P., Kiss J.P., Spedding M. et al. The hippocampal-prefrontal pathway: the weak link in psychiatric disorders? Eur. J. Psychotraumatol. 2013; 23: 1165-81.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Adhikari A., Topiwala M.A., Gordon J.A. Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 2009; 65: 257-69.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mendez-Davida I., Hen R., Gardiera A.M. et al. Adult hippocampal neurogenesis: An actor in the antidepressant-like action. Ann. Pharm. Fr. 2013; 71: 143-9.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Calcia M.A., Bonsall D.R., Bloomfield P.S. et al. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 2016; 233: 1637-50.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Maier S.F. Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain, Behav. Immun. 2003; 17: 69-85.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013; 53: 52-62.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hou R., Baldwin D.S. A neuroimmunological perspective on anxiety disorders. Hum. Psychopharmacol. 2012; 27: 6-14.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Miller A.H., Haroon E., Raison C.L. et al. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013; 30(4): 297-306.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Erta M., Quintana A., Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 2012; 8: 1254-66.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Müller N., Manfred A. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 1998; 22: l-33.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Garay P.A., McAllister A.K. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front. Synaptic Neurosci. 2010; 2: 136.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gola H., Engler H., Sommershof A. et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 2013; 13: 40.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Simen В.В., Duman C.H., Simen A.A. et al. TNFa signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006; 59: 775-85.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Andrews J.A., Neises K.D. Cells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central disease. J. Neurochem. 2012; 120: 26-36.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Ajmo C.T. Jr., Vernon D.O., Collier L. et al. The spleen contributes to stroke-induced neurodegeneration. J. Neurosci. Res. 2008; 86: 2227-34.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lewitus G.M., Cohen H., Schwartz M. Reducing posttraumatic anxiety by immunization. Brain, Behav. Immun. 2008; 22: 1108-14.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Haas H.S., Schauenstein K. Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology. Prog. Neurobiol. 1997; 51: 195-222.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011; 130: 226-38.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Kheirbek M.A., Klemenhagen K.C., Sahay A. et al. Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders. Nat. Neurosci. 2012; 15: 1613-20.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Griffin G.D., Charron D., Al-Daccak R. Post-traumatic stress disorder: revisiting adrenergics, glucocorticoids, immune system effects and homeostasis. Clin. Transl. Immunology 2014; 3(11): e27.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Умрюхин А.Е. Нейромедиаторные гиппокампальные механизмы стрессорного поведения и реакций избегания. Вестник новых медицинских технологий 2013; 1.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Herman J.P. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 1201-13.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Fanselow M.S. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 2010; 65: 7-19.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Nicholson L.B. The immune system. Essays Biochem. 2016; 60: 275-301.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Morganti-Kossmann M.C., Rancan M., Stahel P.F. et al. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 2002; 8: 101-5.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Iłżecka J. The structure and function of blood-brain barrier in ischaemic brain stroke process. Ann. Univ. Mariae Curie Sklodowska Med. 1996; Section D: Medicina; 51: 123-7.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Papadopoulos M.C., Lamb F.J., Moss R.F. et al. Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex. Clin. Sci. 1999; 96(5): 461-6.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Varatharaj A., Galea I. The blood-brain barrier in systemic inflammation. Brain, Behav. Immun. 2017; 60: 1-12.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Ericsson A., Liu C., Hart R.P. et al. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-in-duced cellular activation. J. Comp. Neurol. 1995; 361(4): 681-98.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 2000; 14: 139-51.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Ganong W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 2000; 27: 422-7.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Cottrell G.T., Ferguson A.V. Sensory circumventricular organs: Central roles in integrated autonomic regulation. Regul. Pept. 2004; 117: 11-23.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Joly J.S., Osório J., Alunni A. et al. Windows of the brain: towards a developmental biology of circumventricular and other neurohemal organs. Seminars in cell &amp; developmental biology 2007; 18(4): 512-24.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Agrawal S., Anderson P., Durbeej M. et al. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 2006; 203(4): 1007-19.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Bush T.G., Puvanachandra N., Horner C.H. et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999; 23(2): 297-308.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Esposito P., Gheorghe D., Kandere K. et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001; 888(1): 117-27.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Roszkowski M., Bohacek J. Stress does not increase blood-brain barrier permeability in mice. J. Cereb. Blood Flow Metab. 2016; 36(7): 1304-15.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Frank M., Weber M.D., Watkins L.R. et al. Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disorders. Neurobiol. Stress 2016; 4: 62-70.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Wohleb E.S., McKim D.B., Sheridan J.F. et al. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front. Neurosci. 2015; 8: 447.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Herbert J., Goodyer I.M., Grossman A.B. et al. Do corticosteroids damage the brain? J. Neuroendocrinol. 2006; 18: 393-411.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Heegde F., De Rijk R.H., Vinkers C. The brain mineralocorticoid receptor and stress resilience. Psychoneuroendocrinology 2015; 52: 92-110.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Walker F.R., Yirmiya R. Microglia, Physiology and Behavior: A Brief Commentary. Brain Behav. Immun. 2016; 55: 1-5.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Pavlov V., Tracey K. The vagus nerve and the inflammatory reflex-linking immunity and metabolism. Nat. Rev. Endocrinol. 2012; 8: 743-54.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Olshansky В. Vagus nerve modulation of inflammation: Cardiovascular implications. Trends Cardiovasc. Med. 2016; 26: 1-11.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Ek M., Kurosawa M., Lundeberg T. et al. Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J. Neurosci. 1998; 18: 9471-9.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Hosoi T., Okuma Y., Matsuda T. et al. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton. Neurosci. 2005; 120: 104-7.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Borovikova L.V., Ivanova S., Zhang M. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Wang H., Yu M., Ochani M. et al. Nicotinic acetylcholine receptor a7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Gallowitsch-Puerta M., Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sciences 2007; 80: 2325-9.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Hamano R., Takahashi H.K., Iwagaki H. et al. Stimulation of a7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 2006; 26: 358-64.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Rosas-Ballina M., Ochani M., Parrish W.R. et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. PNAS USA 2008; 105: 11008-13.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Hamilton N.B., Attwell D. Do astrocytes really exocytose neurotransmitters? Nat. Rev. Neurosci. 2010; 11: 227-38.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Hertz L., Zielke H.R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 2004; 27: 735-43.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Kettenmann H., Hanisch U.K., Noda M. et al. Physiology of microglia. Physiol. Rev. 2011; 91: 461-553.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Wake H., Moorhouse A.J., Jinno S. et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 2009; 29: 3974-80.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Chaouloff F. Serotonin, stress and corticoids. J. Psychopharmacol. 2000; 14: 139-51.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Curzon G., Joseph M.H., Knott P.J. Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J. Neurochem. 1972; 19: 1967-74.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Neckers L., Sze P.Y. Regulation of 5-hydroxytryptamine metabolism in mouse brain by adrenal glucocorticoids. Brain Res. 1975; 93: 123-32.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Dunn A.J., Welch J. Stress and endotoxin induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity. J. Neurochem. 1991; 57: 1615-22.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Boadle-Biber M.C. Biosynthesis of serotonin. In: Osborne N.N., editor. Biology of Serotonergic Transmission. Chichester: John Wiley &amp; Sons; 1982. p. 63-87.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Green R.A. Neuropharmacology of 5-hydroxytryptamine. Br. J. Pharmacol. 2006; 147: 145-52.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Dahlström A., Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964; 20: 398-9.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Törk I. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 1990; 600: 9-34.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Risch S.C., Nemeroff C.B. Neurochemical alterations of serotonergic neuronal systems in depression. J. Clin. Psychiatry 1992; 53: 3-7.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Temel Y., Boothman L.J., Blokland A. et al. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. PNAS USA 2007; 43: 17087-92.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Graeff F.G. Role of 5-HT in defensive behavior and anxiety. Rev. Neurosci. 1993; 4: 181-212.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Umbriaco D., Garcia S., Beaulieu C. et al. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus 1995; 5(6): 605-20.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Bunin M.A., Wightman R.M. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 1998; 18(13): 4854-60.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Zoli M., Jansson A., Sykovâ E. et al. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 1999; 20(4): 142-50.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992; 72(1): 165-229.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Peyron C., Petit J.M., Rampon C. et al. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neurosci. 1997; 82; 443-68.</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Mahe C., Loetscher E., Dev K.K. et al. Serotonin 5-HT 7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology 2005; 49: 40-7.</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Kolodzie czak M., Béchade C., Gervasi N. et al. Serotonin modulates developmental microglia via 5-HT2B receptors: potential implication during synaptic refinement of retinogeniculate projections. ACS Chem. Neurosci. 2015; 6: 1219-30.</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>MacGillivray L., Reynolds K.B., Sickand M. et al. Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. Synapse 2011; 65(11): 1166-72.</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>de las Casas-Engel M., Dominguez-Soto A., Sierra-Filardi E. et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J. Immunol. 2013; 190(5): 2301-10.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Hayley S., Merali Z., Anisman H. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness. Stress 2003; 6: 19-32.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Bertrand J., José L.V. A brief overview of multitalanted microglia. In: Bertrand J., José L.V., editors. Microglia: Methods and Protocols. New York: Humana Press Inc; 2013. p. 3-8.</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Burrell R. Immunomodulation by bacterial endotoxin. Crit. Rev. Microbiol. 1990; 17: 189-208.</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Montero-Menei C.N., Sindji L., Garcion E. et al. Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res. 1996; 724: 55-66.</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Pugh C.R., Kumagawa K., Fleshner M. et al. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain, Behav. Immun. 1998; 12: 212-29.</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Swiergiel A.H., Dunn A.J. Effects of interleukin-1beta and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav. 2007; 86: 651-9.</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Silverman M.N., Macdougall M.G., Hu F. et al. Endogenous glucocorticoids protect against TNF-alpha-induced increases in anxiety-like behavior in virally infected mice. Mol. Psychiatry 2007; 12: 408-17.</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Koo J.W., Duman R.S. Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory. Neurosci. Lett. 2009; 456: 39-43.</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Murray C.L., Obiang P., Bannerman D. et al. Endogenous IL-1 in Cognitive Function and Anxiety: A Study in IL-1RI2/2 Mice. PLoS One 2013; 8: 10.</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Muhie S., Gautam A., Chakraborty N. et al. Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder. Transl. Psychiatry 2017; 7: 5.</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Pulli B., Chen J.W. Imaging Neuroinflammation - from Bench to Bedside. J. Clin. Cell. Immunol. 2014; 5: 226.</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Cho W., Barcelon E., Lee S. Optogenetic Glia Manipulation: Possibilities and Future Prospects. Exp. Neurobiol. 2016; 25: 197-204.</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Almli L.M., Fani N., Smith A.K. et al. Genetic approaches to understanding post-traumatic stress disorder. Int. J. Neuropsychopharmacol. 2014; 17(2): 355-70.</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Breen M., Maihofer A., Glatt S. et al. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol. Psychiatr. 2015; 20: 1538-45.</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Uddin M., Aiello A.E., Wildman D.E. et al. Epigenetic and immune function profiles associated with posttraumatic stress disorder. PNAS USA 2010; 107: 9470-5.</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Rusiecki J., Byrne C., Galdzicki Z. et al. PTSD and DNA methylation in select immune function gene promoter regions: a repeated measures case-control study of U.S. military service members. Front. in Psychiatry 2013; 4: 56.</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Albrecht D., Granziera C., Hooker J. et al. In vivo imaging of human neuroinflammation. ACS Chem. Neurosci. 2016; 7: 470-83.</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>De Lange G.M. Understanding the cellular and molecular alterations in PTSD brains: The necessity of post-mortem brain tissue. Eur. J. Psychotraumatol. 2017; 8: 1.</mixed-citation></ref></ref-list></back></article>
